It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
WASHINGTON — The Biden administration announced last Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
An estimated 7.4 million people would gain access to weight-loss drugs like Ozempic and Zepbound, which have out-of-pocket ...